Chemicals

3-(3-chloropropyl)-7,8-dimethoxy-1H-3-benzazepin-2-one

We are 3-(3-chloropropyl)-7,8-dimethoxy-1H-3-benzazepin-2-one CAS:85175-59-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:3-(3-chloropropyl)-7,8-dimethoxy-1H-3-benzazepin-2-one

CAS.NO:85175-59-3

Synonyms:3-(3-chloropropyl)-7,8-dimethoxy-1H-3-benzazepin-2-one

3-(3-Chloropropyl)-1,3-dihydro-7,8-dimethoxy-2H-3-benzazepin-2-one

(Z)-3-(3-chloropropyl)-7,8-diethyl-1H-benzo[d]azepin-2(3H)-one

2H-3-Benzazepin-2-one,3-(3-chloropropyl)-1,3-dihydro-7,8-dimethoxy

Physical and Chemical Properties:

Density 1.2±0.1 g/cm3

Boiling Point 484.1±45.0 °C at 760 mmHg

Molecular Formula C15H18ClNO3

Molecular Weight 295.761

Flash Point 246.6±28.7 °C

Vapour Pressure 0.0±1.2 mmHg at 25°C

Index of Refraction 1.545

Specification:

Appearance:White to off-white powder

Assay:≥98.0%

Melting Point:105-106°C

Packing:25 kg/drum, can also be packaged according to customer requirements

Storage:Store in a cool, ventilated place

Application:Intermediate of Ivabradine(CAS:155974-00-8) and Ivabradine hydrochloride(CAS:148849-67-6).

3-(3-chloropropyl)-7,8-dimethoxy-1H-3-benzazepin-2-one

Related News: We are pleased to work with Inceptua, given their strong record of administering such programs successfully.”/ Oligomannate, which uses extract from marine brown algae as raw material, received a conditional green light to treat mild-to-moderate level AD, the National Medical Products Administration (NMPA) said in a statement on its website late on Saturday.Triisopropylsilane CAS:6485-79-6 Oligomannate, which uses extract from marine brown algae as raw material, received a conditional green light to treat mild-to-moderate level AD, the National Medical Products Administration (NMPA) said in a statement on its website late on Saturday.25526-93-6 Oligomannate, which uses extract from marine brown algae as raw material, received a conditional green light to treat mild-to-moderate level AD, the National Medical Products Administration (NMPA) said in a statement on its website late on Saturday.Oligomannate, which uses extract from marine brown algae as raw material, received a conditional green light to treat mild-to-moderate level AD, the National Medical Products Administration (NMPA) said in a statement on its website late on Saturday.

Product Name
3-Chlorobenzaldehyde Cas:587-04-2	View Details
2-phenoxyaniline Cas:2688-84-8	View Details
4-bromo-2-nitro-1-(trifluoromethyl)benzene	View Details